<unk> , sold under the brand name Ajovy, is a medication used to prevent migraines in adults. It is given by injection under the skin. The most common side effect is pain and redness at the site of injection. Other side effects include allergic reactions. It is in the calcitonin gene-related peptide antagonist class of medications. It was approved for medical use in the United States in 2018, the European Union in 2019 and the UK in 2020.
Fremanezumab
Ustekinumab
Tralokinumab
Olaratumab
Evolocumab
Bezlotoxumab
Alirocumab
Durvalumab